An Equivalence Study of Two Low-Molecular-Weight Heparins in the Prevention and Treatment of Deep-Vein Thrombosis after Total Hip Replacement

ABSTRACT

Low-molecular-weight heparins have been evaluated against unfractionated heparin and have been shown to have clinical benefits in the perioperative setting during orthopedic surgery. Two low-molecular-weight heparins, tinzaparin and enoxaparin, were assessed for equivalency in efficacy and safety in 499 patients undergoing elective hip replacement. The two anticoagulants were found to be effective and safe in this setting in the specified patient type. No statistical difference was observed in the incidence of bleeding. Clinical side effects tended to be greater in patients with a higher body mass index, which could serve as a possible indicator for the risk of deep vein thrombosis.

KEYWORD

Low-molecular-weight heparin - enoxaparin - tinzaparin - deep-vein thrombosis - clinical equivalency - orthopedic surgery

REFERENCES

• 1 Leizorovicz A, Haugh M C, Chapuis F-R, Samama M M, Boissel J-P. Low molecular weight heparin in prevention of perioperative thrombosis.  BMJ . 1992;  305 913-920
• 2 Nurmohamed M T, Rosendaal F R, Büller H R. Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: A meta-analysis.  Lancet . 1992;  340 152-156
• 3 Planès A. Comparison of antithrombotic efficacy and haemorrhagic side-effects of reviparin-sodium versus enoxaparin in patients undergoing total hip replacement surgery.  Blood Coagul Fibrinol . 1993;  4(suppl 1) S33-S35
• 4 Planès A, Samama M M, Lensing A WA. Prevention of deep vein thrombosis after hip replacement. Comparison between two low-molecular-weight heparins, tinzaparin and enoxaparin.  Thromb Haemost . 1999;  81 22-25
• 5 Planès A, Vochelle N, Fagola M, Bellaud M. Comparison of two low-molecular-weight heparins for the prevention of postoperative venous thromboembolism after elective hip surgery. Reviparin Study Group.  Blood Coagul Fibrinol . 1998;  9 499-505
• 6 Bara L, Planès A, Samama M-M. Occurrence of thrombosis and haemorrhage, relationship with anti-Xa, anti-IIa activities, and D-dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgery.  Br J Haematol . 1999;  104 230-240
• 7 Planès A, Vochelle N, Fagola M, Feret J, Bellaud M. Prevention of deep vein thrombosis after total hip replacement. The effect of low-molecular-weight heparin with spinal and general anaesthesia.  J Bone Joint Surg Br . 1991;  73 418-422
• 8 Samama C M, Clergue F, Barre J. Low molecular weight heparin associated with spinal anesthesia and gradual compression stockings in total hip replacement surgery.  Br J Anaesth . 1997;  78 660-665